⏳ 11/21/2023: Natural News > Prostate cancer: In a phase II clinical trial involving 30 men with castration-resistant prostate cancer (CRPC), researchers investigated the efficacy of a combination treatment that involves six cycles of docetaxel/prednisone and daily oral doses of curcumin. - #Cancer

11/21/2023 

Evangelyn Rodriguez

naturalnews.com

They reported that curcumin had a high response rate and helped reduce levels of prostate-specific antigen (PSA), a non-specific marker of prostate cancer, in the participants. Curcumin was also well-tolerated and did not cause any adverse effects, making it a promising treatment for prostate cancer.

According to cell culture and animal studies, curcumin can inhibit prostate tumor growth and metastasis and induce apoptosis (programmed cell death) of prostate cancer cells. (Related: Curcumin found to stop cancer cell growth.)

-